Aliskiren Hemifumarate/Amlodipine Besilate/Hydrochlorothiazide

半延胡索酸阿利吉仑/苯磺酸氨氯地平/氢氯噻嗪

Report date: 2026/01/21 14:10:49

Base Information

Drug NameAliskiren Hemifumarate/Amlodipine Besilate/Hydrochlorothiazide
Drug Alias NameAliskiren Hemifumarate, Amlodipine Besilate and Hydrochlorothiazide半延胡索酸阿利吉仑/氢氯噻嗪/苯磺酸氨氯地平阿利吉仑+氨氯地平+氢氯噻嗪Aliskiren Hemifumarate/Amlodipine Besylate/HydrochlorothiazideRasitrio +[6] 
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated calcium channel blockersRenin inhibitorsThiazide-sensitive sodium-chloride cotransporter inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporterVoltage-gated calcium channelRenin
Therapy Area/IndicationsEssential HypertensionHypertension
Global Approved IndicationsEssential HypertensionHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2010/12/21
Country/TerritoryCanadaUnited StatesVenezuela +[12] 
CombinationsYes HydrochlorothiazideAliskiren HemifumarateAmlodipine Besylate
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma AgNovartis Europharm Ltd
Active IndicationsHypertension
Inactive IndicationsEssential Hypertension

Other Information

ATC CodeC09XA54
Related LinksKEGG